Literature DB >> 1904399

Activation of mouse peritoneal macrophages by maintenance in serum-free medium.

L Walker1, D B Lowrie, R Barclay, G Dixon, K Saunders, P W Andrew.   

Abstract

Normal mouse peritoneal macrophages maintained in a serum-free medium for 48-72 h and then stimulated with phorbol myristate acetate, zymosan or bacteria, released large amounts of hydrogen peroxide. Opsonized zymosan and bacteria stimulated greater release than their unopsonized counterparts. Enhanced peroxide production was not a consequence of increased uptake of particles. Addition of serum to the serum-free medium abolished activation. The addition of interferon-gamma to the serum-free medium enhanced the effect of the serum-free treatment of macrophages from C3H/HeJ mice but abolished the effect of serum free treatment of macrophages from CFLP mice. The results are discussed in terms of negative regulation of receptor-oxidase linkage by serum.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1904399      PMCID: PMC1384526     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  17 in total

1.  Serumless medium for cultivation of cells of normal and malignant origin.

Authors:  R E NEUMAN; A A TYTELL
Journal:  Proc Soc Exp Biol Med       Date:  1960-06

2.  Trace levels of bacterial lipopolysaccharide prevent interferon-gamma or tumor necrosis factor-alpha from enhancing mouse peritoneal macrophage respiratory burst capacity.

Authors:  A H Ding; C F Nathan
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

3.  A simple, rapid, and sensitive DNA assay procedure.

Authors:  C Labarca; K Paigen
Journal:  Anal Biochem       Date:  1980-03-01       Impact factor: 3.365

4.  Induction of synthesis of components of the hydrogen peroxide-generating oxidase during activation of the human monocytic cell line U937 by interferon-gamma.

Authors:  P W Andrew; A K Robertson; D B Lowrie; A R Cross; O T Jones
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

5.  The monocyte in cellular immunity.

Authors:  G B Mackaness
Journal:  Semin Hematol       Date:  1970-04       Impact factor: 3.851

6.  Secretion of a macrophage-activating factor distinct from interferon-gamma by human T cell clones.

Authors:  P W Andrew; A D Rees; A Scoging; N Dobson; R Matthews; J T Whittall; A R Coates; D B Lowrie
Journal:  Eur J Immunol       Date:  1984-10       Impact factor: 5.532

7.  Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters.

Authors:  M Castagna; Y Takai; K Kaibuchi; K Sano; U Kikkawa; Y Nishizuka
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

8.  Hydrogen peroxide and superoxide release by alveolar macrophages from normal and BCG-vaccinated guinea-pigs after intravenous challenge with Mycobacterium tuberculosis.

Authors:  P S Jackett; P W Andrew; V R Aber; D B Lowrie
Journal:  Br J Exp Pathol       Date:  1981-08

9.  Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma.

Authors:  H W Murray; G L Spitalny; C F Nathan
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

10.  Fibronectin and serum amyloid P component stimulate C3b- and C3bi-mediated phagocytosis in cultured human monocytes.

Authors:  S D Wright; L S Craigmyle; S C Silverstein
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

View more
  3 in total

1.  Innate immune properties of the immortalized macrophage cell line I-9.5.

Authors:  W Chang; S H Yeh; D B Drath
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-01       Impact factor: 2.416

Review 2.  In vitro assessments of nanomaterial toxicity.

Authors:  Clinton F Jones; David W Grainger
Journal:  Adv Drug Deliv Rev       Date:  2009-04-19       Impact factor: 15.470

3.  Effects of serum on cytotoxicity of nano- and micro-sized ZnO particles.

Authors:  I-Lun Hsiao; Yuh-Jeen Huang
Journal:  J Nanopart Res       Date:  2013-08-27       Impact factor: 2.253

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.